Classes
Publications
- Calgizzarin (S100A11): a novel inflammatory mediator associated with disease activity of rheumatoid arthritis2017 | First Faculty of Medicine
- Novel adipokine fibroblast growth factor 21 is increased in rheumatoid arthritis2012 | First Faculty of Medicine
- No effect of physiotherapy on the serum levels of adipocytokines in patients with ankylosing spondylitis2012 | First Faculty of Medicine
- Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration2012 | First Faculty of Medicine
- Pentosidine, an Advaced Glycation End_Product, May Reflect Clinical and Morphological Features and Hand Osteoarthritis2012 | First Faculty of Medicine
- NK and NKT cells increase after rituximab treatment in patients with rheumatoid arthritis2011 | First Faculty of Medicine
- Decreases in serum levels of S100A8/9 (calprotectin) correlate with improvements in total swollen joint count in patients with recent-onset rheumatoid arthritis2011 | First Faculty of Medicine
- Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire2011 | First Faculty of Medicine
- 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis2011 | First Faculty of Medicine
- The level of serum visfatin (PBEF) is associated with total number of B cells in patients with rheumatoid arthritis and decreases following B cell depletion therapy2011 | First Faculty of Medicine
Loading network view...